Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 |
|---|---|---|---|
| Total income (before exceptional items) | 1,016† | 1,076† | — |
| Net profit | 248 | 305 | 164 |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| Akshay Bansarilal Arora | Executive Director | June 30, 2026 |
| Naresh Suryakant Shah | Executive Director | June 30, 2026 |
| Popat Bhagwan Kedar | Executive Director | June 30, 2026 |
| Shiven Bansarilal Arora | Executive Director | June 30, 2026 |
| Divya Sameer Momaya | Independent Director | June 30, 2026 |
| Girish Paman Vanvari | Independent Director | June 30, 2026 |
| Preeti Gautam Mehta | Independent Director | June 30, 2026 |
| Priyanka Yadav | Independent Director | June 30, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
